{"id":323251,"date":"2026-11-16T10:03:08","date_gmt":"2026-11-16T04:18:08","guid":{"rendered":"https:\/\/insurancekhabar.com\/?p=323251"},"modified":"2026-11-16T10:05:05","modified_gmt":"2026-11-16T04:20:05","slug":"kantipur-pharmaceuticals-ipo-issue-date-when-can-i-fill-it-2","status":"publish","type":"post","link":"https:\/\/english.insurancekhabar.com\/kantipur-pharmaceuticals-ipo-issue-date-when-can-i-fill-it-2\/","title":{"rendered":"Kantipur Pharmaceuticals IPO Issue Date, When Can I Fill It?"},"content":{"rendered":"<p>Kathmandu. Kantipur Pharmaceuticals Lab Limited is issuing primary shares (IPO) from November 10. The company is going to issue IPO for the local residents of the project-affected area and Nepalis who are in foreign employment. <\/p>\n<p>The company is going to issue 8 lakh units of its issued capital of Rs 800 million at a face value of Rs 100 per share i.e. Panchkhal Municipality Ward No. 10 of Kavrepalanchowk district. The company is going to issue 8 lakh units of shares worth Rs 100 per share. It is going to be issued to the local residents of Kavrepalanchowk district. <\/p>\n<p>Similarly, the company is issuing 90,000 units of shares worth 10 percent to the general public after obtaining labour permit from the concerned body of the government. <\/p>\n<p>Local residents can apply for a minimum of 10 units of shares and a maximum of 10,000 units of shares can be applied. Nepalese working abroad can apply for a minimum of 10 units and a maximum of 7,000 units. <\/p>\n<p>Residents of the project-affected areas will be able to apply by December 13 at the earliest and till December 27 at the latest. Nepalis who are in foreign employment can apply till December 1. If the full application is not received by that period, they can apply till December 10. <\/p>\n<p>Muktinath Capital Limited has been appointed as the issue manager for the IPO issuance. Locals of the project-affected areas can apply from the branches of Muktinath Bikas Bank and Sindhu Bikas Bank in Banepa and Panchkhal. <\/p>\n<p>Care Ratings Nepal has assigned a CareNP Double B Plus Issue Rating rating to the company in the rating for the IPO issuance. This indicates that there is moderate risk to the company&#8217;s ability to bear its obligations. <\/p>\n<p>Local residents will have to pay a fee of Rs 2 for the application form to get the share purchase application. Nepalis who are in foreign employment can apply through the C-ASBA system by using the software &#8216;Mero Share&#8217; developed by all ASBA member banks and financial institutions approved by the Securities Board of Nepal and their designated branch offices and CDS and Clearing Limited.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kathmandu. Kantipur Pharmaceuticals Lab Limited is issuing primary shares (IPO) from November 10. The company is going to issue IPO for the local residents of the project-affected area and Nepalis who are in foreign employment. The company is going to issue 8 lakh units of its issued capital of Rs 800 million at a face [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":199766,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[45159,45180],"tags":[],"class_list":["post-323251","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-stockmarket-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/posts\/323251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/comments?post=323251"}],"version-history":[{"count":1,"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/posts\/323251\/revisions"}],"predecessor-version":[{"id":323252,"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/posts\/323251\/revisions\/323252"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/media\/199766"}],"wp:attachment":[{"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/media?parent=323251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/categories?post=323251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.insurancekhabar.com\/ikbrapi\/wp\/v2\/tags?post=323251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}